Search results
Found 1348 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
University of Oxford to study nasal administration of COVID-19 vaccine
Clinical Trials Coronavirus COVID-19 General
26 March 2021
The University of Oxford is launching a study investigating the delivery of the ChAdOx1 nCoV-19 coronavirus vaccine using a nasal spray.
AstraZeneca publish primary analysis from US trial of coronavirus vaccine
Clinical Trials Coronavirus COVID-19 General Research
25 March 2021
Our partners AstraZeneca have today announced the high-level results from the primary analysis of their Phase III trial of the ChAdOx1 nCoV-19 coronavirus vaccine in the US. They confirm that the vaccine efficacy is consistent with the interim analysis results announced on Monday 22 March 2021.
New partnership enables access to state-of-the-art radiotherapy machine
General Research
25 March 2021
The first NHS patient has received treatment on the cutting-edge ViewRay MRIdian technology, thanks to a new partnership between the University of Oxford, Oxford University Hospitals (OUH) NHS Foundation Trust and GenesisCare.
World TB Day: Finding new ways to test children for tuberculosis
General Research
24 March 2021
Dr Nisreen Khambati of the Oxford Vaccine Group writes for the Oxford Science Blog on why it is vital to find new ways to test children for tuberculosis.
Marking 100 years of the tuberculosis BCG vaccine
General
24 March 2021
The VALIDATE Network, a community of over 400 researchers based in more than 200 research institutions in 63 countries, will today launch the “BCG100 Programme” marking the centenary of the Bacille Calmette-Guérin Vaccine for tuberculosis.
The RECOVERY Trial: One year on
Coronavirus COVID-19 General Research
23 March 2021
The Randomised Evaluation of COVid-19 thERapY (RECOVERY) trial was officially launched on 23 March 2020. It is the world's largest COVID-19 drug trial.
COVID-19: how to tackle vaccine hesitancy among BAME groups
Coronavirus COVID-19 General Research
22 March 2021
USA, Chile and Peru interim trial data show Oxford-AstraZeneca vaccine is safe and highly effective
Clinical Trials Coronavirus COVID-19 General Research
22 March 2021
A Phase III study of the Oxford-AstraZeneca coronavirus vaccine conducted by AstraZeneca plc in the USA, Chile and Peru has shown that vaccine is safe and highly effective, adding to previous trial data from the United Kingdom, Brazil and South Africa, as well as real-world impact data from the United Kingdom.
Oxford awarded major funding to probe childhood poverty and social inequalities
Awards and Appointments General Research
19 March 2021
Ground-breaking multi-disciplinary research is to be launched today by the University of Oxford into the impact of poverty and social inequalities in early childhood, thanks to major funding from the Leverhulme Trust.
Innovation award for Professor Anindita Roy to develop new treatments for childhood cancer
Awards and Appointments General Innovation Research
18 March 2021
Associate Professor Andi Roy leads one of the five research teams across the UK that have been awarded the 2021 Cancer Research UK-Children with Cancer UK Innovation Award. The awards, which provide a total of £4.3 million in scientific funding, will allow leading researchers in the field to delve into the biology of children’s and young people’s cancers, with the hope of finding new ways to prevent and treat these complex cancers.
Two doses of vaccine offer same protection from COVID as prior infection, study finds
Coronavirus COVID-19 General Research
15 March 2021
Two doses of either the Pfizer or Oxford-AstraZeneca vaccine offer similar protection against symptomatic SARS-CoV-2 infection to that coming from natural immunity after infection, an ongoing study of healthcare workers has found.
Association of Physicians of Great Britain and Ireland Annual Meeting opens to wider medical community for first time in over a century
Events General
15 March 2021
Established in 1907, the Association of Physicians of Great Britain and Ireland (AoPGBI) has traditionally only invited the highest-profile doctors and researchers to its annual meeting. Now, they have made the landmark decision to open their (virtual) doors to the wider medical community, primarily to clinicians, early career researchers, discovery scientists and industry affiliates.
Two Oxford pioneers honoured on Sherrington Building Plaques
Awards and Appointments General
12 March 2021
Honouring the heritage of pioneering physiologists Sir Charles Sherrington and Florence Buchanan. "Commemorating both pioneers together highlights the importance of advocacy and mentoring that was evident over a century ago as equality was championed." (Professor David Paterson, Head of Department, Department of Physiology, Anatomy & Genetics)
Professor Cecilia Lindgren appointed Director of the Big Data Institute
Awards and Appointments General
10 March 2021
Professor Cecilia Lindgren has been appointed as the new Director of the University of Oxford’s Big Data Institute.
Characterising SARS-CoV-2 genetic diversity and transmission
Coronavirus COVID-19 General Research
9 March 2021
Adaptive mutations of SARS-CoV-2 are rare and unlikely to be transmitted, but when they are transmitted they can have a big impact, finds a new study.
Oxford medical researchers named NIHR Senior Investigators
Awards and Appointments General
9 March 2021
Five leading healthcare academics in Oxford have been named National Institute of Health Research (NIHR) Senior Investigators
Rare Disease Day 2021: Pandemic response prepares us for next major challenge
General Research
9 March 2021
Success in QS Subject Ranking
Awards and Appointments General
9 March 2021
Oxford Medical Sciences has come top in two subject areas in the latest and internationally-respected QS rankings.